Annette Bruls's most recent trade in Edwards Lifesciences Corp was a trade of 109 Common Stock done at an average price of $78.8 . Disclosure was reported to the exchange on July 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Edwards Lifesciences | Annette Bruls | CVP, EMEACLA | Payment of exercise price or tax liability using portion of securities received from the company at price $ 78.80 per share. | 11 Jul 2025 | 109 | 14,171 (0%) | 0% | 78.8 | 8,589 | Common Stock |
| Edwards Lifesciences | Annette Bruls | CVP, EMEACLA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 31,600 | 31,600 | - | - | Employee Stock Option (Right to Acquire) | |
| Edwards Lifesciences | Annette Bruls | CVP, EMEACLA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 6,200 | 6,200 | - | - | Performance Rights | |
| Edwards Lifesciences | Annette Bruls | CVP, EMEACLA | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 6,200 | 14,280 (0%) | 0% | 0 | Common Stock |